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Bacterial lipopolysaccharide (LPS)  1 has been shown to substitute for helper T cells in 
the production of humoral antibody.  For instance,  cultures of T cell-depleted murine 
spleen cells produce antibody to sheep erythrocytes when LPS is added  (1)  and LPS 
facilitates the formation of antibody to haptens on nonimmunogenic carriers such as 
autologous erythrocytes (2) or amino acids  (3),  for which helper T cells do not exist. 
Recently we  have  reported that  injection of LPS to bacille  Calmette-Gu~rin-infected 
mice causes the release of a factor into the serum which also substitutes for helper T 
cells (4). Because serum produced in this fashion causes acute necrosis of subcutaneous 
tumor grafts,  it is termed tumor necrosis serum  (TNS) (5),  and its tumor-necrotizing 
component is  referred to as  tumor necrosis factor (TNF)  (6).  TNF is contained in  a 
glycoprotein fraction (mol wt 150,000) which migrates with the a2 macroglobulins (6). 
Although the factor that substitutes for T cells is also found in that fraction, it is not 
known if the two are identical. The cellular source of TNS has not yet been identified 
but some of the findings point to the macrophage (5). 
On the basis  of these recent results,  we have examined the hypothesis that 
macrophages play a critical role in the LPS-induced augmentation of the B-cell 
response, and that TNS contains mediators elaborated by macrophages. Essen- 
tial features of our experiments are (a) the use of a  mouse strain unresponsive 
to  LPS  (C3H/HeJ)  (7-10),  and  its  histocompatible  responsive  counterpart 
(C3HeB/FeJ), and  (b) the use of an antigen,  2,4,6-trinitrophenol (TNP)-conju- 
gated  mouse  erythrocytes  (MRBC-TNP),  which  is  not  immunogenic  when 
given  alone  but becomes immunogenic when  given with  LPS  (2).  We  report 
here that (a) LPS enables spleen cells from C3HeB/FeJ but not C3H/HeJ mice 
to produce antibody to MRBC-TNP in tissue culture,  (b) TNS enables spleen 
cells from both mouse strains to produce antibody to MRBC-TNP,  (c) LPS fails 
to support  antigen-dependent production of antibody by macrophage-depleted 
spleen cells from C3HeB/FeJ mice, (d) TNS supports antigen-dependent produc- 
tion in the same setting,  and  (e) addition of C3HeB/FeJ macrophages permits 
C3H/HeJ spleen cells to produce antibody to MRBC-TNP in the presence of LPS. 
* Supported in part by The National Cancer Institute grants CA 08748 and CA 17673, and by 
The American Cancer Society grants IM 82 and IM 87. 
Abbreviations  used  in  this  paper:  LPS,  lipopolysaccharide; MRBC,  routine  erythrocytes; 
PFC, plaque-forming cells; TNF,  tumor necrosis factor; TNP,  2,4,6-trinitrophenol; TNS,  tumor 
necrosis serum. 
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Materials  and  Methods 
Animals  and Antigens.  Male  C3HeB/FeJ  mice and  male  C3H/HeJ  mice,  supplied  by The 
Jackson Laboratory (Bar Harbor, Maine) were used. Sheep and horse erythrocytes were obtained 
from the Colorado Serum Co.  (Denver, Colo.).  Mouse erythrecytes (MRBC) were obtained from 
the same mice from which the spleen cells were prepared.  Erythrocytes were conjugated with 
TNP by the method of Rittenberg and Pratt (11),  as modified by Kettman and Dutton (12). 
Cell Culture.  Spleen cells were cultured according to the method of Mishell and Dutton (13) 
except that 2-mercaptoethanol  5 ×  i0  -~ M  was added to the culture  medium unless stated 
otherwise.  Adherent peritoneal  cells  as  a source of  macrophages (14)  were obtained by incubating 
peritoneal  cells  from normal mice for  2 h in plastic  dishes (model no. 3001,  Falcon  Plastics,  Div. 
of  BioQuest, Oxnard, Calif.)  and removing nonadherent cells  by repeated washing. Spleen cells 
were then added to the peritoneal  cells  that remained. Macrophages were removed from spleen 
cell  suspensions by  passing them through Sephadex G-10  columns as described  by Ly and Mishell 
(15).  One volume Sephadex G-10 was washed five  times in  five  volumes distilled  water  and twice 
in saline.  30-ml aliquots  of  Sephadex G-10 in saline  were autoclaved at 110°C for 30 rain  and 
stored at room temperature.  Columns were prepared by loading sterile  10-ml plastic  syringe 
barrels with 8 ml Sephadex G-10,  warmed up to 42°C,  and washing the Sephadex with 20 ml 
balanced salt  solution  (13),  also  at  42°C. 
Assay for  Plaque-Forming Cells  (PFC).  Cells  producing antibody to TNP were assayed by 
the method of  Rittenberg and Pratt (11)  as modified by Kettman and Dutton (12),  using TNP 
conjugated with HRBC. 
LPS, Lipoprotein,  and TATS.  LPS-sodium salt  was prepared by phenol-water extraction of 
Salmonella abortus-equi  and subsequent electrodialysis  (s --- 100S).  Lipoprotein from the outer 
cell  wall  ofEscherichia  coli  was  prepared  as  previously  described  (16).  TNS prepared  as  described 
previously,  was  provided  by  L.  J.  Old  and  E. Carswell,  Memorial  Sloan  Kettering Cancer  Center. 
Results 
Effects of TNS and LPS on the Production of Antibody to MRBC-TNP by 
Spleen Cells from LPS-Responder and Nonresponder Strains.  In the first set 
of experiments,  the effects of TNS and LPS on the  production of anti-hapten 
antibody by spleen cell cultures immunized with haptenated autologous eryth- 
rocytes  were  compared.  Spleen  cells  were  obtained  from  C3HeB/FeJ  mice 
(responsive  to  LPS)  and  C3H/HeJ  mice  (unresponsive  to  LPS).  Autologous 
erythrocytes were conjugated with TNP as described before (11, 12). Aliquots of 
approximately  l0  s  MRBC  were  incubated  with  increasing  amounts  of 2,4,6- 
trinitrobenzene sulfonic acid (Fig.  1) to obtain different hapten densities on the 
erythrocyte  surface.  1 million  MRBC-TNP were  added to  spleen  cells  which 
were cultured according to the method described by Mishell and Dutton (13). 
Antibody formation was measured in terms of the number of PFC.  Anti-TNP 
PFC were counted after a 4-day culture period (12). Antibody production in the 
absence  of antigen  will  be  referred  to  as  polyclonal  response  (17),  antibody 
production  resulting  from  exposure  to  MRBC-TNP  as  antigen-dependent  re- 
sponse. 
In  the  absence  of TNS  or  LPS,  addition  of MRBC-TNP failed to  induce  a 
significant number of anti-TNP PFC in cultures of spleen cells from both C3H 
substrains  (Fig.  1). Addition of LPS caused an antigen-dependent  response as 
well as  a  polyclonal response  in  cultures  of C3HeB/FeJ spleen cells,  but not 
(over a wide dose range) in cultures of C3H/HeJ spleen cells. Addition of TNS, 
on the  other  hand,  facilitated the  antigen-dependent  response  in  cultures  of 
spleen cells from both substrains  (but not,  as noted previously, the polyclonal 
response).  Optimal  antigenicity  of MRBC-TNP  was  obtained  by  incubating 1642  MACROPHAGES  MEDIATE  LIPOPOLYSACCHARIDE  ADJUVANTICITY 
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FIG.  1.  Facilitation  of anti-TNP  response by  LPS  or  by  TNS.  10 7 spleen  cells  from 
C3HeB/FeJ mice  (A)  or C3H/HeJ  mice (B)  were immunized with 10  ~ MRBC conjugated 
with TNP at different densities. Amount of 2,4,6-trinitrobenzene sulfonic acid per 10  ml 
buffer containing 10  ~ MRBC is indicated on the abscissa. Additions to cultures: O,  none; 
O, TNS 1%; A, LPS 10 ~g/ml. 
MRBC in a solution that contained 10 mg trinitrobenzene sulfonic acid per 10 
ml buffer. More heavily conjugated erythrocytes  were less immunogenic unless 
T  cells  (presumably  suppressor  cells)  were  removed from  the  spleen  cell 
suspension by treatment with anti-Thy-1 serum and complement before culture 
(not shown here). 
Responder Macrophages  Support  the LPS-Induced Production  of Antibody 
to MRBC-TNP in Nonresponder  Mice.  To determine the role of macrophages 
in the antigen-dependent as well as polyclonal production of antibody, macro- 
phages were removed  from spleen cell suspensions by passage through Sephadex 
G-10 columns (15). LPS did not support the antigen-dependent production of 
antibody in macrophage-depleted C3HeB/FeJ spleen cell cultures, although it 
continued to induce the polyclonal response. By contrast, TNS supported the 
antigen-dependent production of antibody by C3HeB/FeJ spleen cells even in 
the absence of macrophages (Table I)o The effectiveness  of LPS in facilitating the 
antigen-dependent production of antibody by macrophage-depleted cultures of 
C3HeB/FeJ spleen cells was fully restored by adding purified peritoneal C3HeB/ 
FeJ macrophages, but not C3H/HeJ macrophages (Fig.  2 A). Spleen cells from 
C3H/HeJ  mice  (unresponsive to  LPS),  responded to  LPS  in the  presence of 
C3HeB/FeJ macrophages and produced antibody to MRBC-TNP. 
Responder Macrophages Fail to Support the LPS-Induced Mitotic Response 
of Nonresponder  B  Cells.  Peritoneal  macrophages  from  C3HeB/FeJ  mice 
(which facilitate formation of antibody to MRBC-TNP by C3H/HeJ spleen cells 
in response to  LPS),  failed completely to  support the mitogenic response of 
C3H/HeJ B cells to LPS (Table II). 
Effects  of Lipoprotein  Extracted from  Gram-Negative  Bacteria.  As there 
are reports that proteins extracted from the outer membrane of gram-negative 
bacteria induce mitosis of C3H/HeJ B cells (10, 16) and phenotypic maturation 
of C3H/HeJ T- and B-cell precursors (18), not seen with pure LPS preparations 
in this strain, we tested a lipoprotein prepared from the outer membrane of E. 
coli for its capacity to induce antigen-dependent  antibody production in cultures Source of spleen  Addition to cul- 
cells (5  x  106/cul - 
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TABLE  I 
Role of Macrophages  in the LPS-Induced Production of Antibody to MRBC-TNP 
LPS  per  ml 
FIG.  2.  Facilitation  of antigen-dependent and  polyclonal  antibody production,  in  the 
presence of LPS, by macrophages from an LPS-responsive mouse strain.  (A)  response of 
macrophage-depleted C3HeB/FeJ spleen cells. (B) response of macrophage-depleted C3H/ 
HeJ spleen cells. Additions to cultures:  0,  none; O,  MRBC-TNP; &, 6  ×  104 C3HeB/FeJ 
macrophages;  A,  6  x  104  C3HeB/FeJ  macrophages  +  MRBC-TNP;  [],  105  C3H/HeJ 
macrophages +  MRBC-TNP. 
of C3H/HeJ spleen cells. We found that the effects of this material on C3H/HeJ 
spleen cells were in fact similar to the effects of LPS on C3HeB/FeJ spleen cells 
(Fig. 3). Spleen cells from C3H/HeJ mice immunized with MRBC-TNP generate 
anti-TNP  PFC  efficiently in  the  presence  of lipoprotein;  only few PFC  were 
induced at the highest dose of lipoprotein when macrophages had been removed. 
Thus,  lipoprotein activates macrophages from both C3H substrains. 
Discussion 
We reported earlier that TNS,  induced by injecting BCG-infected mice with 
LPS (5), replaces helper T cells in the PFC response to heterologous erythrocytes 
in vitro  (4),  and induces phenotypic and functional maturation  of B cells (19). 1644  MACROPHAGES  MEDIATE  LIPOPOLYSACCHARIDE  ADJUVANTICITY 
TABLE  II 
Failure of LPS to Stimulate Mitosis of C3H/HeJ B  Cells 
Source of spleen cells 
Source of macro- 
phages 
Addition 
None  LPS 1 ~g/ml 
(106/ml)  (5  × 104/ml)  ([3H]Thyrnidine  cpm) 
C3HeB/FeJ  -  215  17,225 
C3HeB/FeJ  395  16,310 
C3H/HeJ  410  16,800 
C3H/HeJ  -  405  525 
C3HeB/FeJ  480  570 
C3H/HeJ  455  465 
Macrophage-depleted spleen cells were cultured (2  ×  105 cells/0.2 ml) with or 
without LPS,  and with or without macrophages,  for 48 h,  and subsequently 
pulsed with [3H]thymidine (0.1 ~Ci) for 2 h. Incorporated [3H]thymidine was 
counted in a liquid scintillation counter. 
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Fro.  3.  Effect  of  bacterial  lipoprotein  on  antigen-dependent  and  polyclonal  antibody 
production by  C3H/HeJ  spleen cells.  Addition to  macrophage-depleted  C3H/HeJ  spleen 
cells  (5 x 10e/ml):  $, none; C), MRBC-TNP;  A, 10  5  C3H/HeJ macrophages;/I,  10  5  C3H/HeJ 
macrophages  +  MRBC-TNP. 
The latter is of particular interest in that TNS, unlike LPS, does not induce 
maturation of T-cell precursors  and is thus the  first agent known to  induce 
selective  differentiation of murine B  cells  (19). The  findings with TNS  add 
support to the notion that LPS exerts various biological effects through endoge- 
nous mediators.  We have pursued this question further in experiments with 
two syngeneic C3H substrains, one responsive to LPS and the other not (7-10), 
and an antigen which is  immunogenic in the presence of LPS but not when 
given  alone.  Schmidtke and  Dixon  showed first that  mice  immunized with 
MRBC-TNP produce antibody to TNP only when treated with LPS (2). They 
attributed the lack of response in the absence of LPS to the lack of MRBC- 
reactive helper T  cells.  We confirm and extend this observation.  Cultures of M.  K.  HOFFMANN,  C.  GALANOS,  S.  KOENIG,  AND  H.  F.  OETTGEN  1645 
unfractionated  spleen  cells  from  C3HeB/FeJ  mice,  exposed to  MRBC-TNP, 
produce antibody to TNP when LPS is added. Spleen cells from C3H/HeJ mice 
(unresponsive  to  LPS)  cannot  be  induced  with  LPS to  produce  antibody to 
TNP.  LPS-induced TNF, on the other hand,  facilitates production of antibody 
to TNP in response to MRBC-TNP in cultures of spleen cells from both strains, 
a finding which adds further support to the contention that the active principle 
in TNS is not residual LPS itself. 
In considering possible cellular sources of TNF, the massive proliferation of 
macrophages caused by the priming agents used in its production has directed 
attention  to the macrophage  (5). Consequently, we examined whether there 
are  similarities  between immunological  effects of macrophages  and  those of 
TNS.  We  found  that  macrophages  are  indispensable  for  the  facilitation  of 
antibody  production  to  MRBC-TNP by  LPS  in  spleen  cell  cultures.  In  this 
reaction,  macrophages  from  a  mouse  strain  which  is  unresponsive  to  LPS 
cannot substitute for macrophages from an LPS-responsive strain even though 
the lymphocytes are from an LPS-responsive strain.  Splenic lymphocytes from 
unresponsive mice, on the other hand, become responsive to MRBC-TNP in the 
presence of LPS when small numbers of macrophages from an LPS-responsive 
strain  are  added.  Thus,  in  terms  of the  antigen-dependent  production  of 
antibody, the defect that makes spleen cells of C3H/HeJ mice unresponsive to 
LPS can be traced to the macrophage. In experiments of this sort, the failure of 
macrophages  to  respond  to  LPS  is  demonstrable  only when  highly  purified 
preparations  of LPS are  used,  and  not  with  lipoprotein-containing  bacterial 
extracts. 
Our  findings  suggest  that  macrophages  play  a  critical  role  in  mediating 
biological effects of LPS. This view is also supported by Schrader's observation 
that  cultured spleen cells from athymic nu/nu mice produce antibody to fowl 
gamma globulin when LPS is added, provided that activated peritoneal macro- 
phages  are  present  (20). In  his  experiments,  the  macrophage  effect  was 
mediated by a trypsin-sensitive factor released as a consequence of the interac- 
tion between macrophages and LPS. Wood and Gaul described a B-cell activat- 
ing factor which is released in vitro by human monocytes in response to LPS (21). 
Macrophages from LPS-responder mice, as well as LPS-induced TNF, facili- 
tate the production of antibody by nonresponder spleen cells in the presence of 
LPS, but fail to support mitosis of nonresponder B lymphocytes in response to 
LPS (reference 9, and confirmed by us). Our findings, summarized in Table III, 
indicate that the two responses represent separate pathways of B-cell activation 
by LPS, one representing direct interaction between LPS and B cells (mitosis), 
the other depending on macrophages or macrophage-produced factors (antigen- 
dependent production of antibody). A dissociation between the adjuvant activity 
of LPS and its mitogenic effect on B cells has  also been suggested by Jacobs 
and Morrison (22) who reported that the cationic polypeptide antibiotic, poly- 
myxin  B,  abrogates  the  mitogenic  effect of LPS but enhances  the  immune 
response to TNP conjugated with LPS. 
Summary 
The role played by macrophages in two effects of lipopolysaccharide (LPS) on 
the immune system of the mouse- substitution for helper T cells and induction 1646  MACROPHAGES  MEDIATE  LIPOPOLYSACCHARIDE  ADJUVANTICITY 
TABLE  III 
Different Requirements of lnduction of Antibody Production or B-Cell Mitosis by LPS 
Antigen-dependent 
production of anti- 
body 
Mitosis 
Unfractionated spleen cells 
Responder +  LPS  +  + 
Nonresponder +  LPS  -  - 
Responder +  TNS  +  - 
Nonresponder +  TNS  +  - 
Macrophage-depleted spleen cells 
Responder +  LPS  -  + 
Nonresponder +  LPS  -  - 
Responder +  TNS  +  - 
Nonresponder +  TNS  +  - 
Nonresponder  spleen  cells  +  responder  macro-  +  - 
phages and LPS 
Responder  macrophage-depleted  spleen  cells  + 
nonresponder macrophages and LPS 
of B-cell mitosis -has been investigated. C3H/HeJ mice are unresponsive and do 
not produce (as other strains do) antibody to 2,4,6-trinitrophenol  (TNP) conju- 
gated  with  autologous  mouse  erythrocytes  (MRBC-TNP)  in  the  presence  of 
LPS.  We  found that  C3H/HeJ spleen  cells produce  antibody to  MRBC-TNP 
when  (a) LPS and macrophages from LPS-responsive C3HeB/FeJ mice or (b) 
tumor necrosis serum  ([TNS] induced by LPS in responsive mice) are added. 
The mitotic response was not restored. The findings suggest that adjuvanticity 
and  mitogenicity  represent  distinct  pathways  of B-cell  activation  by  LPS, 
subject to different regulatory mechanisms. 
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